Effects of Glucagon-Like Peptide-1 Receptor Agonists on Glucocorticoid-Induced Osteoporosis Glucocorticoid (GC) treatment is the main cause of secondary osteoporosis
GLP-1 Receptor Agonists: The primary mechanism of action for both medications involves the activation of GLP-1 receptors, leading to improved insulin sensitivity and glucose regulation
There were cases of MTC reported in patients who took liraglutide (the active ingredient in Victoza and Saxenda) after the drug was put on the market
Kiecolt-Glaser JK, Epel ES, Belury MA, Andridge R, Lin J, Glaser R, Malarkey WB, Hwang BS, Blackburn E (2013) Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: a randomized controlled trial
Its especially effective when used alongside lifestyle changes, hormone balancing, detoxification protocols, and nutritional support, all customized to your individual needs and biochemistry